Exciting new research is revealing that psychedelic drugs, such as psilocybin and MDMA, may offer significant benefit for patients struggling at the end of life and those beset by major depressions and treatment-resistant post-traumatic stress.
DPA is co-organizing and co-sponsoring this day-long symposium along with the End of Life Liberty Project and University of Washington. This conference brings together doctors, scientific researchers, attorneys and ethicists to consider the medical, legal and ethical implications of this evolving research and to situate our evolving understanding of psychedelics in the shifting policies and priorities of our state and national drug control strategies.
We’ll be joined in Seattle by some fantastic speakers – including MAPS Executive Director Rick Doblin, Washington State Representative Roger Goodman and End of Life Liberty Project Executive Director Kathryn Tucker.
This event will take place at the University of Washington School of Law in William H. Gates Hall. You must register to attend. Lunch will be provided.